Akebia Therapeutics, Inc.
NASDAQ:AKBA
1.35 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| -51.925 | -92.562 | -282.84 | -383.457 | -279.659 | -143.588 | -76.914 | -135.747 | -60.716 | -37.034 | -13.167 | -8.196 |
| Depreciation & Amortization
| 41.846 | 37.697 | 37.97 | 33.59 | 38.646 | 2.421 | 0.617 | 0.296 | 0.096 | 0.049 | 0.001 | 0 |
| Deferred Income Tax
| 6.792 | 0 | 36.578 | 204.078 | -6.631 | -28.338 | 0 | 0 | 0 | 0 | -2.42 | 0 |
| Stock Based Compensation
| 9.317 | 17.849 | 22.735 | 24.46 | 11.925 | 19.04 | 8.867 | 5.825 | 4.714 | 6.01 | 1.564 | 0.122 |
| Change In Working Capital
| -20.727 | -1.435 | -108.418 | -13.67 | -99.069 | 36.018 | 7.248 | 186.732 | 2.941 | 3.224 | 1.93 | -0.808 |
| Accounts Receivables
| 0.994 | 11.695 | -24.022 | 12.011 | -22.198 | 33.384 | -0.393 | -33.823 | 0 | 0.087 | -0.05 | -0.004 |
| Inventory
| -2.542 | 19.793 | -25.847 | 6.163 | -29.142 | 0.026 | 16.79 | 0 | 0 | -0.773 | 0 | 0 |
| Accounts Payables
| -5.244 | 1.501 | -11.735 | 3.678 | 1.372 | 13.717 | 4.959 | -0.274 | 0.231 | 4.061 | 0 | 0 |
| Other Working Capital
| -13.935 | -34.424 | -46.814 | -35.522 | -49.101 | -11.109 | -14.108 | 187.006 | 2.71 | -0.151 | 1.98 | -0.804 |
| Other Non Cash Items
| -8.687 | -34.703 | 41.01 | 24.611 | 77.347 | 16.953 | 4.023 | 0.8 | 0.558 | 0.268 | 0.76 | 1.671 |
| Operating Cash Flow
| -23.384 | -73.154 | -252.965 | -110.388 | -257.441 | -97.494 | -56.159 | 57.906 | -52.407 | -27.483 | -11.332 | -7.211 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| 0 | -0.114 | -0.059 | -0.317 | -6.655 | -1.606 | -1.622 | -2.662 | -0.414 | -0.229 | -0.02 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 39.687 | 0 | 6.147 | 1.622 | 2.662 | 0.414 | 0.229 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | -99.932 | 0 | -224.216 | -330.636 | -147.009 | -77.175 | -77.708 | -13.395 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 40 | 60.245 | 217.831 | 256.269 | 154.998 | 162.376 | 63.901 | 12.585 | 1.99 | 1.366 |
| Other Investing Activites
| 0 | 0 | 40 | -39.687 | 217.831 | 32.053 | -1.622 | -2.662 | -0.414 | -0.229 | -11.406 | 1.366 |
| Investing Cash Flow
| 0 | -0.114 | 39.941 | -40.004 | 211.176 | 36.594 | -177.26 | 12.705 | -13.688 | -65.352 | -11.425 | 1.366 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| -32 | -33 | -44.783 | -19.975 | -15 | -0.019 | -0.005 | -0.02 | -0.007 | -0.003 | 0 | 0 |
| Common Stock Issued
| 6.794 | 7.121 | 88.202 | 209.419 | 25.785 | 96.581 | 114.58 | 66.736 | 82.75 | 104.328 | 0.005 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | -0.426 | 0 | 0 | 0 | 0 | -0.162 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -31.914 | 40.477 | 90.312 | 42.276 | 78.611 | 96.581 | 1.665 | 0.23 | 0.35 | 0.237 | 42.325 | 2.475 |
| Financing Cash Flow
| -25.206 | 14.598 | 133.731 | 231.72 | 88.97 | 96.562 | 116.24 | 66.946 | 83.093 | 104.4 | 42.331 | 2.475 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -47.541 | -58.67 | -79.293 | 81.328 | 42.705 | 35.662 | -117.179 | 137.557 | 16.998 | 11.565 | 19.574 | -3.37 |
| Cash At End Of Period
| 42.925 | 93.169 | 151.839 | 231.132 | 149.804 | 107.099 | 70.156 | 187.335 | 49.778 | 32.78 | 21.215 | 1.641 |